3,4-Dihydro-2h-1,5-benzodioxepin-6-ylboronic acid, 95%, 1g

N-Cyclohexylbenzamide, 95%, 5g

2-((Dimethylamino)methyl)cyclohexanone hydrochloride, 95.0%, 10g

CNQX>98.0%(HPLC)50mg

Ethyl 1,4-dimethylpiperazine-2-carboxylate, 95.0%, 250mg

N,N,N-Triethylbenzenaminium iodide, 95.0%, 5g

Lithium fluoride, min. 99%, pa, 25 g, plastic packaging.

4-Bromo-6-methylisoquinoline, 95.0%, 5g

4'-Iodoacetophenone>98.0%(GC)25g

[1-(2-Amino-ethyl)-piperidin-3-yl]-carbamic acid tert-butyl ester, 95.0%, 500mg

1-(4-Fluorophenyl)-2-propanol, 97.0%, 250mg

5-(2-chloroethyl)-1-methyl-1H-pyrazole hydrochloride, 95.0%, 500mg

3-bromo-4-(methylsulfanyl)benzaldehyde, 95.0%, 250mg